Table 2 Stereotactic body radiotherapy dosimetry and treatment details.

From: First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias

Median target volume, cm3 (range)

Internal target volume (ITV)

15.4 (4.6–40.9)

Planning target volume (PTV)

52.0 (14.4–92.6)

Dosimetry analysis, median (range)

ITV, DMax (Gy)

31.0 (29.7–32.3)

ITV, D98% (Gy)

24.8 (24.4–24.9)

ITV, D95% (Gy)

25.1 (25.0–25.5)

ITV, D1% (Gy)

30.2 (29.2–30.9)

PTV, D98% (Gy)

19.4 (19.0–19.7)

PTV, D95% (Gy)

20.1 (20.0–20.7)

PTV, D1% (Gy)

29.7 (29.0–30.3)

Skin, Dmax (Gy)

8.6 (4.9–13.9)

Rib, Dmax (Gy)

13.3 (5.8–25.5)

Trachea and large bronchus, Dmax (Gy)

1.4 (0.3–12.2)

Spinal cord, Dmax (Gy)

2.1 (1.3–4.6)

Stomach, Dmax (Gy)

3.4 (0.1–12.0)

Esophagus, Dmax (Gy)

5.2 (2.7–14.9)

Coronary arteries, Dmax (Gy)

19.0 (8.4–21.8)

Heart minus PTV, > 16.0 Gy (cm3)

12.7 (7.7–14.9)

Lung, < 7.0 Gy (cm3)

2403 (2041–3739)

Liver, < 9.1 Gy (cm3)

1120 (954–1828)

SBRT energy, n (%)

6 MV FFF

2 (28.5)

10 MV FFF

5 (71.5)

Median SBRT employed partial arcs, number (range)

Total arcs

10 (9–13)

Coplanar arcs

6 (5–9)

Non-coplanar arcs

4 (4–4)

Median SBRT monitor units, MU (range)

8898 (6431–12,092)

Median SBRT treatment time, min (range)

12.7 (9.2–17.3)

  1. SBRT stereotactic body radiotherapy, FFF flattening filter-free photon beam, Dmax maximal dose within the volume, D98%, D95%, and D1% minimum coverage dose of 98%, 95%, and 1% of the target volumes, respectively, Heart minus PTV, heart volume excluding the PTV; > 16.0 Gy, volume receiving at least 16 Gy; < 7.0 Gy and < 9.1 Gy, volumes receiving < 7 Gy and 9.1 Gy, respectively.